Social Prescribing to promote and improve access to health and care services for people in vulnerable situations in Europe

Find out more about objectives and impact

Social Prescribing (SP) is an innovative solution to bridging the gap between primary health care and non-clinical supports and services within the community. SP enables general practitioners who identify health-related social problems to refer patients to a so-called link worker. The link worker provides personalized support and helps these patients to access community resources by addressing any barriers that may exist.

SP is an approach to integrate health and social care and strengthen community orientation. SP thereby mitigates the effects of social determinants of health on health outcomes. However, SP has not been tailored to the needs of people in vulnerable situations yet and the effectiveness of SP to improve their access to health and care services remains unknown.

  • project duration

    5 years
  • grant amount

    6.970.269,74 €
  • 14 countries

    22 institutions
  • start

    1st January 2025

objectives

The overall objective of SP-EU is to assess the potential of SP to promote and improve access to health and care services for people in vulnerable situations, focusing on three primary target groups: LGBTIQ persons, refugees and first-generation immigrants and older adults living alone. SP-EU follows a mixed-methods approach: SP adaptations will be co-created with the target groups, to adapt them to their specific needs and social contexts. A pragmatic randomized controlled trial will assess the effectiveness of the adapted SP to improve access by randomizing 1,776 patients in eight EU countries to receive SP or care as usual.

A qualitative analysis in five European countries will explore enabling and limiting factors to the implementation of SP from different stakeholders’ perspectives. Additionally, we will communicate and disseminate results and translate them into policy action. SP-EU will enable health care systems to implement SP as a scalable, safe, cost-effective and people-centred solution to provide equal access to sustainable care. Thus, SP-EU will enable the transformation of European health care systems to equitable, community-based, people-centred and integrated health care.

Impact

SP-EU will contribute to the Key Strategic Orientation D in Horizon Europe’s Strategic Plan 2021-2024, creating a more resilient, inclusive and democratic European society by addressing inequalities and providing high-quality health and social care. Thus, SP-EU contributes to the impact area of “good health and high-quality accessible healthcare” in this Key Strategic Orientation.

Social Prescribing strengthens the community orientation and health-promoting aspects of health care, mitigating the effects of social determinants of health and reducing the need for treatment, thereby improving the sustainability of health services. SP-EU will contribute to the expected impact No. 4, ensuring access to innovative, sustainable and high-quality health care of cluster health.

Contact

Scientific Coordinator:

Charité Universitätsmedizin Berlin
Institute of General Practice and Family Medicine
Prof. Wolfram Herrmann
Chariteplatz 1
10117 Berlin
Germany

Contact : wolfram.herrmann@charite.de

Project Management:

concentris research management gmbh
Sonja Leissner

Ludwigstr. 4‍
82256 Fürstenfeldbruck
Germany

Email: sonja.leissner@concentris.de